Published in Obesity and Diabetes Week, January 14th, 2008
"Here, we report the generation of mice lacking GSK-3 alpha. Unlike GSK-3 beta mutants, which die before birth, GSK-3 beta knockout (GSK-3 alpha KO) animals are viable but display enhanced glucose and insulin sensitivity accompanied by reduced fat mass. Fasted and glucose-stimulated hepatic glycogen...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.